EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy

por Evans, A H, Pancholi, S, Farmer, I, Thornhill, A, Evans, D B, Johnston, S R, Dowsett, M, Martin, L-A
Publicado 2010